769 results on '"Gaynon, Paul"'
Search Results
202. Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group
203. Expression of Aberrantly Spliced Oncogenic Ikaros Isoforms in Childhood Acute Lymphoblastic Leukemia
204. Treatment Outcome and Prognostic Factors for Infants With Acute Lymphoblastic Leukemia Treated on Two Consecutive Trials of the Children's Cancer Group
205. Low-Dose Cyclosporin A Therapy in Children With Refractory Immune Thrombocytopenic Purpura
206. Poor Treatment Outcome of Philadelphia Chromosome-Positive Pediatric Acute Lymphoblastic Leukemia Despite Intensive Chemotherapy
207. Prognostic Significance of T-Lineage Leukemic Cell Growth in SCID Mice: A Children's Cancer Group Study
208. Reply
209. Prognostic Significance of B-Lineage Leukemic Cell Growth in SCID Mice: A Children's Cancer Group Study
210. Primary Blasts from Infants with Acute Lymphoblastic Leukemia Cause Overt Leukemia in SOD Mice
211. Treatment of Human B-Cell Precursor Leukemia in SCID Mice by Using a Combination of the Anti-CD19 Immunotoxin B43-PAP with the Standard Chemotherapeutic Drugs Vincristine, Methylprednisolone, and L-Asparaginase
212. Distinct in Vivo Engraftment and Growth Patterns of t(1;19)+/E2A-PBX1+and t(9;22)+/BCR-ABL+Human Leukemia Cells in SCID Mice
213. Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia
214. Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study
215. Acute Lymphoblastic Leukaemia
216. Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative
217. Prognostic Significance of the CD10+CD19+CD34+B-Progenitor Immunophenotype in Children with Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group
218. Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: A report from the children's cancer group
219. Improved Clinical Outcome for Children with T-Lineage Acute Lymphoblastic Leukemia After Contemporary Chemotherapy:A Children's Cancer Group Study
220. The Use of Glucocorticoids in Acute Lymphoblastic Leukemia of Childhood Molecular, Cellular, and Clinical Considerations
221. Acute leukemia in children
222. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group
223. Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant.
224. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: A report from the childrens cancer group
225. Studies Strategies and Design
226. Childhood leukemia and lymphoma
227. Boitezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
228. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
229. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
230. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study.
231. Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium.
232. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): Review from an international consensus conference.
233. Granulocytic Sarcoma of the Ileum treated by Bone Marrow Transplantation
234. Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
235. Relapsed acute lymphoblastic leukemia: Current status and future opportunities.
236. Treating refractory leukemias in childhood, role of clofarabine.
237. Treatment of pediatric acute lymphoblastic leukemia: Progress achieved and challenges remaining.
238. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG-1941).
239. Methotrexate and asparaginase: not so simple.
240. Carboplatin in childhood brain tumors: A children's cancer study group phase II trial
241. Childhood acute lymphoblastic leukaemia and relapse.
242. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
243. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
244. Population Pharmacokinetics of Clofarabine, a Second-Generation Nucleoside Analog, in Pediatric Patients With Acute Leukemia.
245. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
246. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
247. Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
248. Expression of TEL-AML 1 Fusion Transcripts and Response to Induction Therapy in Standard Risk Acute Lymphoblastic Leukemia.
249. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia.
250. A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.